Open access · US-GOV via ClinicalTrials.gov Clinical trial

Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease

Authors not listed

Mayo Clinic · 2018

Stem-cell exhaustion Chronic inflammation Senolytics Stem-cell therapy Human Randomized controlled trial

Abstract

The proposed studies will examine the effect of fisetin on adipose tissue-derived mesenchymal stem/stromal cell function, kidney function, markers of inflammation, and physical function in individuals with advanced chronic kidney disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Anonymous. (2018). Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease. <em>Mayo Clinic</em>. https://clinicaltrials.gov/study/NCT03325322

Vancouver

Anonymous. Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease. Mayo Clinic. 2018.

BibTeX

@misc{anon2018Frailt, title = {Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease}, author = {Anonymous}, journal = {Mayo Clinic}, year = {2018}, }